Bullfrog AI (BFRG) Competitors $1.47 -0.04 (-2.65%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$1.46 0.00 (-0.34%) As of 07:38 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFRG vs. MNOV, ACHL, PDSB, IPA, OTLK, INMB, IRD, NRXP, VTGN, and UNCYShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include MediciNova (MNOV), Achilles Therapeutics (ACHL), PDS Biotechnology (PDSB), ImmunoPrecise Antibodies (IPA), Oncobiologics (OTLK), INmune Bio (INMB), Opus Genetics (IRD), NRx Pharmaceuticals (NRXP), VistaGen Therapeutics (VTGN), and Unicycive Therapeutics (UNCY). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. Its Competitors MediciNova Achilles Therapeutics PDS Biotechnology ImmunoPrecise Antibodies Oncobiologics INmune Bio Opus Genetics NRx Pharmaceuticals VistaGen Therapeutics Unicycive Therapeutics MediciNova (NASDAQ:MNOV) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations. Which has more risk and volatility, MNOV or BFRG? MediciNova has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Is MNOV or BFRG more profitable? MediciNova's return on equity of -20.77% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets MediciNovaN/A -20.77% -19.68% Bullfrog AI N/A -163.23%-139.94% Which has better valuation & earnings, MNOV or BFRG? Bullfrog AI has lower revenue, but higher earnings than MediciNova. MediciNova is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMediciNova$1M60.33-$11.04M-$0.23-5.35Bullfrog AI$60K230.79-$6.99M-$0.81-1.81 Does the media refer more to MNOV or BFRG? In the previous week, MediciNova had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 2 mentions for MediciNova and 1 mentions for Bullfrog AI. MediciNova's average media sentiment score of 0.94 beat Bullfrog AI's score of 0.86 indicating that MediciNova is being referred to more favorably in the media. Company Overall Sentiment MediciNova Positive Bullfrog AI Positive Do analysts prefer MNOV or BFRG? MediciNova currently has a consensus target price of $7.00, indicating a potential upside of 469.11%. Given MediciNova's stronger consensus rating and higher possible upside, equities research analysts plainly believe MediciNova is more favorable than Bullfrog AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MediciNova 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in MNOV or BFRG? 9.9% of MediciNova shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 13.6% of MediciNova shares are held by insiders. Comparatively, 33.9% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryMediciNova beats Bullfrog AI on 11 of the 16 factors compared between the two stocks. Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.22M$2.00B$5.61B$9.29BDividend YieldN/AN/A4.23%4.03%P/E Ratio-1.8134.2528.5419.58Price / Sales230.7915.04429.2495.01Price / CashN/A54.7436.0257.93Price / Book2.588.258.145.54Net Income-$6.99M-$62.39M$3.24B$257.73M7 Day Performance-1.34%-2.22%0.18%-0.08%1 Month Performance-15.52%9.89%5.96%8.09%1 Year Performance-51.32%3.14%26.24%13.02% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI0.4541 of 5 stars$1.47-2.6%N/A-45.6%$14.22M$60K-1.814MNOVMediciNova1.6241 of 5 stars$1.25flat$7.00+460.0%-13.4%$61.31M$1M-5.4310Gap DownACHLAchilles TherapeuticsN/A$1.48flatN/AN/A$60.83MN/A-0.90250PDSBPDS Biotechnology1.3109 of 5 stars$1.22-8.3%$9.00+637.7%-72.3%$60.79MN/A-1.3020IPAImmunoPrecise Antibodies3.0027 of 5 stars$1.63+24.4%$4.00+145.4%+86.3%$59.95M$18.16M-1.4180Upcoming EarningsGap UpOTLKOncobiologics2.2906 of 5 stars$1.86+4.5%$9.60+416.1%-73.1%$59.75MN/A-2.0420Gap UpINMBINmune Bio2.3053 of 5 stars$2.30-9.1%$18.40+700.0%-78.3%$59.67M$10K-1.1910Positive NewsHigh Trading VolumeIRDOpus Genetics1.8569 of 5 stars$0.99-0.8%$7.33+639.2%N/A$59.66M$10.99M-0.4714NRXPNRx Pharmaceuticals2.7406 of 5 stars$3.37-0.3%$28.50+745.7%+30.1%$58.44MN/A-1.682VTGNVistaGen Therapeutics1.1025 of 5 stars$2.21+10.5%N/A-42.5%$58.31M$490K-1.3340News CoveragePositive NewsHigh Trading VolumeUNCYUnicycive Therapeutics2.9853 of 5 stars$4.69+2.0%$60.00+1,179.3%-7.4%$58.15MN/A-0.929High Trading Volume Related Companies and Tools Related Companies MediciNova Competitors Achilles Therapeutics Competitors PDS Biotechnology Competitors ImmunoPrecise Antibodies Competitors Oncobiologics Competitors INmune Bio Competitors Opus Genetics Competitors NRx Pharmaceuticals Competitors VistaGen Therapeutics Competitors Unicycive Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRG) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
